Retrospective analysis of the risk factors, outcome, antimicrobial cost and susceptibility for bacteremia caused by ESBL-producing enterobacteriaceae

JRCT ID: jRCT1040230081

Registered date:25/09/2023

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: bacteremia
• Date of first enrollment: 02/10/2023
• Target sample size: 1000
• Study type: Observational

Outcome(s)

• Primary Outcome: compare esbl group and non-esbl group

Secondary Outcome

outcome
cost of antimicrobial therapy
susceptibility

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable

Include criteria

inpatient from 4/1/201 to 3/31/2023
bacteremia caused by enterobacteriaceae

• Exclude criteria: contamination

Related Information

• Primary Sponsor: Kato Jun